BNT162b2 immunization-related myocarditis in adolescents and consequent hospitalization: Report from a medical center

BACKGROUND: To investigate Pfizer-BioNTech 162b2 mRNA COVID-19 vaccine (BNT162b2) immunization-related myocarditis and describe the risk factors for consequent hospitalization in the pediatric intensive care unit (PICU) in children between 12 and 18 years. METHODS: Children and adolescents 12 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Chen-Wei, Lee, Jung, Chang, Ya-Ting, Lee, En-Pei, Wu, Chang-Teng, Chang, Yi-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205643/
https://www.ncbi.nlm.nih.gov/pubmed/37302919
http://dx.doi.org/10.1016/j.pedneo.2023.01.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205643/
https://www.ncbi.nlm.nih.gov/pubmed/37302919
http://dx.doi.org/10.1016/j.pedneo.2023.01.005

Ejemplares similares